|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM130788023 |
| 003 |
DE-627 |
| 005 |
20250204102348.0 |
| 007 |
tu |
| 008 |
231222s1956 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed25n0436.xml
|
| 035 |
|
|
|a (DE-627)NLM130788023
|
| 035 |
|
|
|a (NLM)13331637
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a GILLETTE, H E
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Relaxant effects of meprobamate in disabilities resulting from musculoskeletal and central nervous system disorders; clinical observation of fifty-five cases
|
| 264 |
|
1 |
|c 1956
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 01.05.2003
|
| 500 |
|
|
|a Date Revised 01.12.2018
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a ANTICONVULSANTS/therapeutic use
|
| 650 |
|
4 |
|a BONES/diseases
|
| 650 |
|
4 |
|a CENTRAL NERVOUS SYSTEM/diseases
|
| 650 |
|
4 |
|a MUSCLE RELAXANTS/therapeutic use
|
| 650 |
|
4 |
|a MUSCLES/diseases
|
| 650 |
|
7 |
|a Anticonvulsants
|2 NLM
|
| 650 |
|
7 |
|a Muscle Relaxants, Central
|2 NLM
|
| 650 |
|
7 |
|a Meprobamate
|2 NLM
|
| 650 |
|
7 |
|a 9I7LNY769Q
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t International record of medicine and general practice clinics
|d 1952
|g 169(1956), 7 vom: 01. Juli, Seite 453-68
|w (DE-627)NLM098172042
|x 0097-1650
|7 nnns
|
| 773 |
1 |
8 |
|g volume:169
|g year:1956
|g number:7
|g day:01
|g month:07
|g pages:453-68
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 169
|j 1956
|e 7
|b 01
|c 07
|h 453-68
|